A key dierence among the three structurally similar pRB family members is that only pRB is a tumor suppressor. Identi®cation of distinctive functional dierences between pRB and p107/p130 therefore holds promise for a better understanding of the tumor suppression mechanisms of pRB. Enigmatically, pRB and p107 have been shown to have indistinguishable growth suppression activities when studied in the pRBde®cient Saos-2 cell system. In this study, we discovered that, when expressed at physiologically relevant levels, pRB and p107 had distinctive eects in causing growth suppression. pRB induced cellular p130 levels while p107 repressed them. p107, but not pRB, blocked cells inside S phase in addition to G1 arrest. In contrast, no qualitative dierences were identi®ed in their abilities to repress the expression of a set of suspected pRB/E2F repression target genes. These results indicate that pRB and p107 possess dierent growth suppression eects, despite the fact that they have similar E2F repression eects.
Introduction
While the retinoblastoma protein pRB is a prototypic tumor suppressor mutated in all the retinoblastomas and a large number of other types of tumors, its two family members, p107 and p130, remain normal in human cancers (Weinberg, 1995) . This unequal involvement in tumorigenesis can also be reproduced in mice with engineered inactivation of these genes . Heterozygous germline inactivation of pRB led to pituitary tumors with full penetrance (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) while similar inactivation of p107 or p130 did not cause tumor development (Cobrinik et al., 1996; Lee et al., 1996) .
Studies with genetically engineered mice have so far provided the best evidence for the functional dierences and overlaps among these three proteins. While mice with p107 or p130 null mutations were normal, mice with both p107 and p130 mutations failed to survive after birth (Cobrinik et al., 1996) . p107 inactivation increased the severity of the lethal phenotypes of pRB null embryos and, using chimera mice, the inactivation of both p107 and pRB led to the development of retinoblastoma (Robanus-Maandag et al., 1998) . Fibroblasts obtained from these knockout animals also have phenotypic dierences. After release from serum starvation, pRB null ®broblasts entered S phase several hours earlier than wild type cells (Herrera et al., 1996; Hurford et al., 1997) . Inactivation of p107 or p130 did not change cell cycle progression kinetics unless both p107 and p130 were inactivated in the cells, which led to faster entry into S phase similar to pRB null cells (Hurford et al., 1997) . When a set of suspected E2F target genes were examined in these cells, it was found that only the expression of cyclin E and p107 were deregulated in pRB de®cient cells, while no detectable changes in gene expression were found in p107 or p130 null cells (Herrera et al., 1996; Hurford et al., 1997) . Combined loss of p107 and p130 led to the deregulation of B-myb, cdc2, E2F1, TS, RRM2, and cyclin A2 (Hurford et al., 1997) . Thus, these proteins, particularly p107 and p130, share biological activities to a signi®cant degree. Recent studies, however, demonstrated that genetic background plays an important role in determining the consequences of p107 or p130 loss in mice (LeCouter et al., 1998a,b) .
In human tumor cells, functions of pRB and its family members have been studied with gain-offunction experiments. When overexpressed, all these proteins can inhibit the proliferation of the pRBde®cient Saos-2 osteosarcoma cells (Claudio et al., 1994; Goodrich et al., 1991; Huang et al., 1988; Qin et al., 1992; Zhu et al., 1993) . Although pRB, p107, and p130 have been found to associate with dierent anities with members of the E2F family in vivo, they can repress the activities of these E2Fs indiscriminately in transient transfection with E2F reporters (Beijersbergen et al., 1994; Ginsberg et al., 1994; Hijman et al., 1995; Lees et al., 1993) . Unlike the loss-of-function studies with knockout mice, gain-of-function studies have so far failed to reveal qualitative functional dierences in their growth suppression and E2F repression activities.
One concern with the gain-of-function studies is that the supra-physiological levels of overexpression may have masked functional dierences among the three proteins. Another limitation is that the eects of pRB proteins on cellular genes and proteins cannot usually be studied in transient expression experiments since transient expression techniques (such as transient transfection and microinjection) can only introduce pRB proteins to a small fraction of cells in the population. Due to the need to coexpress a transfection marker, cell cycle studies after transient transfection are limited to one parameter analysis (the DNA content). In this study, we have established controlled expression systems for pRB and p107 to address these issues.
Results
Inducible expression of moderate levels of pRB and p107 in pRB-deficient Saos-2 cells pRB re-expression in pRB-de®cient osteosarcoma Saos-2 cells is a useful assay from which most of our current knowledge about the function of pRB has been learned. We established Saos-2 cell derivatives in which the expression of pRB or p107 is controlled by the tetracycline regulated promoter (Gossen and Bujard, 1992) .
We ®rst con®rmed that the expression of pRB and p107 was indeed induced in most of the cells after the withdrawal of tetracycline. Indirect immuno¯uores-cence staining with anti-pRB and anti-p107 antibodies showed that more than 90% of the cells in the population expressed the intended proteins in the nucleus (data not shown). We then compared the levels of pRB and p107 after induction to those found in the ML1 human myeloblastic leukemia cells, which are known to contain easily detectable amounts of pRB and p107. Figure 1a shows that when equal amounts of proteins from total cell lysates were prepared on the same gel and probed with anti-pRB or anti-p107 antibodies, protein levels of pRB and p107 in ML-1 and induced Saos-2 cells were very similar. When compared to endogenous p107 levels in Saos-2 cells, the induction increased the p107 levels about ®vefold. We also compared pRB levels in induced cells to those achieved after transient transfection with a CMV based constitutive pRB expression vector CMVpRB, with which most of the previous pRB studies were conducted. Although only 5% of the cells were successfully transfected, as determined by FACS analysis with a GFP marker, pRB levels in total extracts after transient transfection were very similar to that achieved after pRB induction (lanes 9 and 10). Thus, the expression of pRB in each individual cells is about 20-fold lower in inducible cells than in successfully transfected cells. Inducible cells with only the empty vector did not show any detectable expression of pRB as expected.
Opposite effects of pRB and p107 on cellular p130 expression
In pRB null MEFs, p107 expression was evaluated (Hurford et al., 1997) , suggesting the existence of interdependent regulation among the three pRB family proteins. To determine whether this relationship could also be demonstrated in our system, we examined the expression levels of all three proteins in each inducible cell lines before and after induction. pRB induction repressed the expression of p107 (Figure 1a , lanes 4 and 5), consistent with results obtained from mouse cells. Interestingly, pRB expression increased p130 Figure 1 Inducible expression of pRB and p107 in Saos-2 cells, and dierent eects of pRB and p107 on cellular p130. (a) Total cell extracts were prepared at 24 h after induction, separated on 10% SDS ± PAGE, and blotted with the indicated antibodies. Equal amounts of proteins, including extracts of ML1 cells, were loaded in each lane. In the CMVpRB lane, a 10 cm plate of Saos-2 cells was transfected with 20 mg of CMVpRB. The asterisk indicates a non-speci®c reaction of anti-p130 antibody to p107. (b) RT ± PCR with primers speci®c for p130 and S16 transcripts from the same induced and uninduced samples as indicated. (c) Saos-2 cells were treated with either LLnL (50 mM) or equal amount of the solvent DMSO for 20 h. Cell extracts were separated on 10% SDS ± PAGE and blotted with the indicated antibodies. (d) Western blotting of induced and uninduced cell extracts for p130, this experiment was performed as in panel A except that a 6% SDS ± PAGE was used. Under this condition, p130 can be separated into three forms of varying degrees of phosphorylation (Mayol et al., 1996) . The asterisk also indicates a non-speci®c reaction of antip130 antibody to p107 levels (lanes 4 and 5). Most notably, p130 protein levels in p107-expressing cells were slightly decreased (lanes 6 and 7). Thus, pRB and p107 were functioning against each other on p130 expression.
Due to the low abundance of p107 and p130 message RNAs in Saos-2 cells, we used RT ± PCR to determine the transcript levels of p130 before and after the induction of pRB or p107. Reactions with dierent numbers of cycles were used to ensure that ampli®ca-tion was within linear range and levels of ribosomal S16 expression were used as control. As shown in Figure 1b , p130 transcript level was signi®cantly increased after pRB induction, suggesting that the increase in p130 proteins after pRB induction was regulated at the transcription level. p107 induction did not alter p130 transcript abundance.
In a previous study using murine ®broblasts, Smith et al. (1998) showed that the accumulation of p130 protein after serum starvation was not accompanied by a signi®cant increase in p130 transcript levels, while the decrease in p130 proteins after serum stimulation was partially blocked by treatment with LLnL, an inhibitor of proteasome activity. We determined the p130 protein levels after LLnL treatment of Saos-2 cells to investigate whether p130 was also degraded by a proteasome-dependent mechanism in these cells. The result shows that p130 protein levels did not change after LLnL treatment, while protein levels of p27 and p21, which are known to be degraded in a proteasomedependent manner (Blagosklonny et al., 1996; Pagano et al., 1995) , increased signi®cantly in the same cells ( Figure 1c) . Thus, the role of protein degradation in the regulation of p130 abundance in Saos-2 cells is not apparent.
In addition to protein abundance, p130 is also regulated by phosphorylation in a cell cycle dependent manner (Mayol et al., 1995) . Unlike pRB, p130 is apparently phosphorylated in G0 cells (Mayol et al., 1995 (Mayol et al., , 1996 . In fact, the appearance of partially phosphorylated p130 form 2 was shown to be characteristic of cell cycle transition from G1 to G0 (Mayol et al., 1996) . Using previously reported electrophoresis conditions, we determined the phosphorylation status of endogenous p130 after pRB or p107 induction. As shown in Figure 1d , pRB induction led to the disappearance of p130 form 3, the accumulation of form 1, and the appearance of form 2. p107 induction also led to the disappearance of form 3. However, the amount of form 1 was decreased and no discrete form 2 was detected. These results indicate that pRB and p107 have distinct eects on p130 phosphorylation as well as its protein levels.
Distinctive effects of pRB and p107 on cell cycle progression
We next determined the biological activities of pRB and p107 after induction. Cell growth curves showed complete suppression of cell proliferation by both pRB and p107 (Figure 2a ). Cells expressing pRB or p107 also enlarged similarly at day 3 after induction and exhibited the¯at cell morphology, as previously observed after transient transfection, at day 7 after induction ( Figure 2b ). Thus, pRB could function eciently as a growth suppressor in Saos-2 cells at moderate levels of expression and, in these assays, p107 functioned indistinguishably from pRB. A previous study found that, in transient transfection with a drug resistance marker, p107 induced about half as manȳ at cells compared with pRB (Sellers et al., 1998) . In that assay however, the number of drug resistant¯at cells also depended on the eciency of transfection. With our inducible cells, we eliminated this variable. Under this condition, most of the cells in the population adopted the¯at cell morphology after p107 induction. When tetracycline was added back to the media after 2 days of induction, cells repressed the levels of pRB and p107 to those seen prior to induction and resumed proliferation (data not shown). In contrast to reversal of arrest by a temperature-sensitive pRB (Tiemann and Hinds, 1998) , no signi®cant apoptosis was observed after the reversal of either pRB or p107 expression (data not shown).
Growth suppression by arresting the cell cycle in G1 is a well established biological function of pRB and p107 in transient transfection and microinjection studies (Goodrich et al., 1991; Hinds et al., 1992; Zhu et al., 1993) . Figure 3a shows such studies with our inducible cells. Although both pRB and p107 induction clearly caused G1 arrest, it is of note that the reduction of S phase population was consistently less pronounced after p107 expression than that after pRB expression as determined by DNA content in histograms. To determine whether the remaining S phase cells after pRB and p107 expression were actively synthesizing DNA, we pulse labeled the cells with BrdU for 30 min before they were harvested for¯ow cytometry analysis. Bivariate analysis with DNA content and BrdU staining is shown in Figure 3b . The R2 window contains cells that have S phase DNA content (between G1 and G2 peaks) and are actively synthesizing DNA (BrdU positive) while R3 area cells are S phase in DNA content but not actively synthesizing DNA (BrdU negative). On average, less than 1% of the total population was found in the R3 area in actively growing cells. After induction of control and pRB inducible cells, R3 cell populations did not change while the R2 cell population decreased signi®cantly after pRB induction, which con®rmed that pRB only arrests cells before they entered S phase (Goodrich et al., 1991) . In contrast, while p107 induction decreased R2 cell populations, R3 populations increased nearly 10-fold, suggesting that p107 was also blocking cells inside the S phase. Thus, the use of bivariate analysis revealed that pRB and p107 had distinct eects on S phase cells.
A potential explanation for the observed dierent cell cycle eects of pRB and p107 is that p107 contains a cyclin/Cdk2 binding domain not found in pRB Faha et al., 1992) . The cyclin binding domain of p107, when overexpressed, was able to inhibit the kinase activities of cyclin/Cdk2 complexes through direct binding (Woo et al., 1997; Zhu et al., 1995b) . pRB, on the other hand, is thought to inhibit Cdk2 activity through repression of cyclin E, cyclin A, and Cdk2 expression. To investigate whether pRB and p107 inhibited Cdk2 activity to dierent degrees, we measured the cellular Cdk2-associated kinase activities after pRB and p107 induction. As shown in Figure 4a , pRB and p107 inhibited Cdk2-associated kinase activity to similar degrees by 24 h after induction, the time point when the BrdU FACS analysis was performed in Figure 3 . The kinetics of Cdk2 inhibition was faster in p107 induced cells (compare 8 h and 12 h time points), and this faster inhibition correlated with binding of p107 with cyclin A and the phosphorylated form of Cdk2 at these early time points (Figure 4b ). However, it is important to note that binding of cyclin A and Cdk2 by p107 was essentially non-detectable when the accumulation of R3 cells became signi®cant later in the time course (Figure 4c ), suggesting that cyclin binding by p107 may not play a direct role in the accumulation of S phase cells after p107 induction.
Since pRB and p107 had dierent eects on cellular p130 protein levels ( Figure 1a ) and overexpression of p130 in Saos-2 cells was able to inhibit proliferation and cause G1 arrest in transient transfection experiments (Claudio et al., 1994; Lacy and Whyte, 1997; Sellers et al., 1998) , we tested the possibility that the increase in p130 protein levels seen after pRB induction was responsible for the dierent eects of pRB and p107 on the cell cycle. We established p130 inducible Saos-2 cells and induced p130 to a range of increasingly higher levels with dierent concentrations of tetracycline in the media (Figure 5a ). Tetracycline concentration of 0.1 ± 0.3 mg/ml induced p130 protein levels to a similar degree as that seen after pRB induction. When cell cycle pro®les of these cells were analysed, it was clear that this level of p130 expression was not sucient for the ecient G1 arrest seen in pRB induced cells (Figure 5a ). In fact, even at higher levels of p130 expression, p130 was unable to cause the same levels of G1 arrest as pRB. Rather, p130 induction also led to the accumulation of cells with S phase DNA content but not incorporating BrdU (Figure 5b) . Thus, p130 accumulation in pRB induced cells was not the likely cause for the dierent eects of pRB and p107 on S phase progression. Overlapping repression effects of pRB and p107 on cellular E2F target genes
We next investigated the eects of pRB and p107 on cellular E2F. pRB and p107 were immunoprecipitated with their speci®c antibodies and the presence of E2F proteins in the immuno-complexes was detected by gel shift with E2F binding site-containing oligonucleotides after DOC treatment. Twenty-four hours after induction, both pRB and p107 immunoprecipitates contained E2F binding activity (Figure 6a ). The identity of E2F in the gel shift complexes was then determined by supershift with antibodies speci®c to individual E2F family members in gel shift assays. The results show that E2F2 and E2F4 were present in both pRB and p107 complexes (Figure 6a ). The lack of detection of E2F1 and E2F3 in the same experiment may be attributable to the low abundance of these two E2F members in DNA binding complexes in Saos-2 cells, since anti-E2F1 and anti-E2F3 antibodies also did not disrupt straight E2F gel shift complexes in Saos-2 cell extracts (data not shown).
Repression of E2F-mediated gene expression is the best studied function of pRB and p107 (Dyson, 1994; . With the inducible cells we examined repression eects of pRB and p107 on most of the suspected target genes in their natural chromosomal environments. Figure 6b shows the representative results. The expression of cell cycle regulators cyclin A, cyclin E, Cdk2 and Cdc2 were indeed eciently repressed after pRB and p107 expression. In contrast, the expression of Cdk4 was not aected in the same cells, indicating that the repression of cell cycle regulators was selective. The phosphatase Cdc25A has recently been identi®ed as an E2F responsive gene (Iavarone and Massague, 1999; Vigo et al., 1999) . Its expression was repressed after pRB and p107 expression. Expression of E2F1, but not E2F3 and E2F4, was eciently repressed by both pRB and p107, so were genes involved in DNA replication initiation and nucleotide synthesis, including Cdc6, Orc1, MCM2, MCM3, MCM5, MCM6, MCM7, DHFR, RRM1, and TS. Although B-myb gene expression was strongly derepressed in p107; p130 double null MEFs but normal in pRB null cells, we found pRB and p107 to be equally ecient in repressing B-myb in Saos-2 cells. Minor dierences in the eects of pRB and p107 on the expression of c-myc were reproducibly observed. While pRB expression resulted in a small decrease in cmyc RNA levels, p107 induction did not change c-myc levels. Our results with pRB are consistent with those reported by (Buchmann et al., 1998) where several of these genes were tested with CMV based overexpression of pRB using adenovirus-mediated gene transfer. Overall, pRB and p107 did not seem to have distinct dierences in their regulation of E2F-dependent transcription, even when analysed on cellular genes in their natural chromosomal environment and at moderate levels of expression achieved in these inducible cells. However, the ®nal determination of whether pRB and p107 repress, or activate, dierent cellular genes will depend on a systematic search for the target genes of these two proteins.
Functional activities of pRB when re-expressed at physiological levels in pRB-deficient tumor cells
To further determine the physiological relevance of the pRB expression levels in our inducible cells, we sought to compare them with an endogenous pRB level that is sucient for growth suppression. We recently established U-2 OS cells with inducible expression of p16 (Jiang et al., 1998) . Induction of p16 caused ecient G1 arrest in U-2 OS cells and this growth suppression was believed to be dependent on endogenous pRB (Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995) , which became hypophosphorylated after p16 expression. The ability of the tetracycline controlled expression system to partially induce the expression of the gene under its control made it possible to determine the lowest pRB expression levels that were still capable of growth suppression. The range of tetracycline concentrations shown in Figure 7a yielded gradually higher pRB expression levels, including levels similar to that found in p16-arrested U-2 OS cells ( Figure 7b ). In parallel, FACS analysis showed the eect of various levels of pRB expression on cell cycle progression ( Figure 7a ). G1 arrest was signi®cant at tetracycline concentrations between 10 and 30 ng/ml, which yielded a pRB expression level similar to that found in p16-arrested U-2 OS cells and ®ve to ten times lower than the levels achieved at full pRB induction (Figure 7b ). We further demonstrated that repression of cyclin A and Cdk2 expression was also signi®cant at 10 ± 30 ng/ml tetracycline concentrations (Figure 7c ). These results demonstrated the ability of pRB to repress the expression of cellular E2F-regulated genes and to cause G1 cell cycle arrest when re-expressed in pRB-de®cient tumor cells at physiological levels. 
Discussion
The fact that only pRB of the pRB family is frequently involved in tumorigenesis clearly indicates that key functional dierences exist between pRB and p107/ p130. Theoretically, the fact that p107 and p130 are more closely related to each other than either is to pRB, can explain the lack of selection of tumor cells with mutations in p107 or p130, since four alleles need to be inactivated for the loss of p107/p130 function while only two alleles need to be inactivated for the loss of pRB function. This assumption, however, has not received experimental support, since p1077/7; p130+/7 or p107+/7; p1307/7 mice did not exhibit obvious tumor phenotypes like pRB+/7 mice . Thus, qualitative dierences must exist in their abilities to suppress tumor formation. Indeed, in loss-of-function studies mouse embryo ®broblasts of pRB7/7 or p1077/7; p1307/7 genotypes exhibited deregulation of dierent E2F target genes (Hurford et al., 1997) , although it remains to be determined whether the observed dierences are responsible for the dierent involvement of RB family members in tumorigenesis. Gain-of-function studies of pRB proteins in pRB de®cient human cancer cells have played a major role in elucidating the functions of these proteins. Whereas most of the currently known functions of pRB proteins are identi®ed in gain-of-function studies, the failure so far of gain-of-function experiments to demonstrate qualitative dierences in growth suppression activities of pRB and p107/p130 is perplexing and poses great diculty to furthering our understanding of these proteins. There could be two general reasons for this lack of distinction. (1) The observed growth suppression activity of pRB is only an overexpression phenotype, and p107 shares this property. (2) pRB and p107 are actually causing dierent growth suppression phenotypes but current assays are unable to reveal the dierences. pRB and p107 inducible cell lines enabled us to investigate these possibilities with three new experimental capacities: the ability to control pRB expression levels and to directly compare them with those in pRB-containing cells; to study the eects of pRB proteins on cellular genes and proteins; and to de®ne S phase progression with bivariate FACS analysis (DNA content and BrdU labeling). With these new experiments, we were able to document that growth suppression by pRB and p107 was not dependent upon supra-physiological levels of expression, and that pRB and p107 had dierent growth suppression activities.
Our ®nding that pRB and p107 had opposite eects on cellular p130 expression and phosphorylation (Figure 1) , and on S phase progression in bivariate FACS analysis (Figure 3) clearly demonstrated for the ®rst time that qualitative functional dierences between pRB and p107 can be assayed in gain-of-function studies. Furthermore, their dierent eects on p130 is most likely of physiological relevance. In many experimental systems involving cell cycle exit and/or entry, p130 levels usually increase in G0 cells while p107 levels usually increase towards G1/S transition (Cobrinik et al., 1993; Smith et al., 1998) . In addition to protein levels, p130 phosphorylation form 2 is speci®cally associated with cell cycle exit to G0 (Garriga et al., 1998; Mayol et al., 1996) . In mouse knockout studies, pRB, but not p107 and p130, has been shown to be essential for entry and/or maintenance of G0 phase in many cell types (myocytes for one example (Novitch et al., 1996; Schneider et al., 1994) ). These previous ®ndings together suggested that pRB, but not p107, plays an important role in cell cycle exit, which is accompanied by the accumulation of p130 protein and its phosphorylation form 2. Our results that pRB, but not p107, can induce the accumulation of p130 levels and phosphorylation form 2 (Figure 1a,d ) have now provided direct experimental evidence, with a gain-of-function approach, for the ability of pRB to induce cell cycle exit, and the inability of p107 to do so despite its many similarities with pRB, particularly with regard to E2F repression.
Since expression of p130 alone was insucient to cause the observed eects of pRB expression ( Figure  5 ), and p130 is apparently not required for cell cycle exit in mice, we believe that other targets of pRB must be involved in cell cycle exit after pRB expression. Since our inducible expression system is capable of revealing functional dierences between pRB and p107 in regulating cell cycle exit, it should also be useful in the identi®cation of these pRB-regulated genes with technologies such as DNA microarray. Identi®cation of cellular genes speci®cally regulated by pRB in cell cycle exit will greatly improve our understanding of the mechanisms of tumor suppression by pRB. Figure 7 Tetracycline concentration titration to induce pRB expression at dierent levels. In (a) and (b), pRB inducible cells were induced for 24 h with various amounts of tetracycline per ml and Western blotted for pRB. Tetp16 is the U-2 OS cell line with inducible expression of p16 (Jiang et al., 1998) . Parallel plates were processed for¯ow cytometry, and the FACS pro®les are presented under the immunoblot in (a). (c) Northern blot analysis on parallel plates induced in a was performed as in Figure 5 Further studies are required to learn whether the eects of pRB on p130 expression are direct. We showed that the accumulation of p130 after pRB expression is most likely due to increased transcription of the cellular p130 gene. Previous studies revealed that the 5' untranscribed region of the p130 gene contained consensus binding sites for Sp1, MyoD, and Ker1 transcription factors, but not E2F (Baldi et al., 1996) . The lack of E2F binding site and the presence of MyoD binding site may explain the stimulation of p130 transcription by pRB, since pRB is known to be able to repress E2F-mediated transcription and to stimulate MyoD-mediated transcription (Gu et al., 1993) . However, although these functions of pRB are shared by p107 (Schneider et al., 1994) , p107 did not stimulate p130 transcription. The presence of multiple Sp1 sites may account for the lack of stimulation by p107, since p107, but not pRB, was able to eciently repress Sp1-mediated transcription in reporter assays (Datta et al., 1995) . A detailed promoter function analysis will be required to con®rm the roles of each of these binding sites in the regulation of the p130 promoter by pRB and p107.
The second qualitative and testable functional dierence identi®ed between pRB and p107 is that p107, but not pRB, was able to block S phase progression in addition to S phase entry when expressed in actively growing cells (Figure 3 ). This dierence could not be discovered in previous studies with DNA content FACS or BrdU labeling, since cells with S phase DNA content but not actively synthesizing DNA will be counted as real S phase cells in DNA content FACS or as non-S phase cells in BrdU incorporation experiments. Inducible expression of pRB or p107 in the whole cell population eliminated the need for a marker for transfected cells so that DNA content and BrdU bivariate FACS analysis could be performed. Whether this function of p107 is related to its inability to drive cells into G0 as suggested by its eects on p130 is not clear at this time since only 5% of the total population was blocked in the S phase as de®ned by their DNA content. It is possible that cells induced to express p107 accumulate mostly near the G1/S transition with some cells in S phase, whereas cells expressing pRB accumulate mostly near the G1/ G0 transition or in G0. Alternatively, the ability of p107 to block S phase progression is a separate functional entity of p107 due to its binding of cyclin/ Cdk2 and more ecient inhibition of Cdk2 associated kinase activity at early times after induction (Figure 4 ). This possibility raises the need to further study the role of Cdk2 in S phase progression. In previous studies, inhibition of Cdk2 by potent inhibitors (such as a dominant negative Cdk2 (van den Heuvel and Harlow, 1993) or the p21/p27 family of CKIs (Harper et al., 1993; Toyoshima and Hunter, 1994) ) led to G1 arrest of cell cycle progression, suggesting that more ecient inhibition of Cdk2 should lead to more ecient block to S phase entry. Bivariate FACS analysis with inducible expression of these inhibitors will be needed to learn whether the inhibition of Cdk2 activity through these inhibitors also lead to a block of S phase progression in addition to S phase entry. Results from these studies will help shed more light on the functional dierence between pRB and p107 in the regulation of G1/S transition and S phase progression.
Materials and methods

Inducible cells and transfections
Saos-2 cells were ®rst transfected with plasmid pUHD15-1 (Gosser and Bujard, 1992) together with pSVneo for G418 selection. Derivative clones that were able to support the tetracycline-controlled expression of pRB from pUHD10-3pRB, which was constructed by inserting a pRB cDNA (Qin et al., 1992) into the BamHI site of pUHD10-3, were ®rst isolated. pUHD10-3pRB, and pUHD10-3p107 (similarly constructed with a p107 cDNA (Zhu et al., 1993) were then transfected into the same clone with pBabePuro for puromycin selection in the presence of tetracycline (1 mg/ ml). Two clones of these cell lines were analysed, yielding identical results. Transfection with the empty vector yielded cell lines for control. Transient transfections and induction of p16 inducible U-2 OS cells were as described (Jiang et al., 1998) . Expression plasmid CMVpRB (Qin et al., 1992) was described previously.
Immunoblot, kinase assay, and FACS analysis
These experiments were performed as previously described (Jiang et al., 1998) . For BrdU bivariate analysis, cells were labeled with BrdU for 30 min, ®xed, and stained with an FITC-labeled anti-BrdU antibody (Becton-Dickinson) according to manufacturer's protocol. The following antibodies were purchased from Santa Cruz: pRB (sc-50), p107 (sc-318), p130 (sc-317), Cdk2 (sc-163), p27 (sc-528), and actin (I-19). Anti-p21 antibody was described previously (Zhu et al., 1995a) .
RT ± PCR
pRB and p107 cells were induced for 24 h and RNA was prepared with Trizol (Gibco). RNA was treated with DNase (Gibco) and reverse transcribed with M-MLV RT (Gibco). Products from reverse transcription were ampli®ed by PCR. Reactions without RT were used as controls. The following sense and antisense PCR primers were used: p130 5'-CTGG-GGAGACTGTTTCTGTCAC-3', 5'-GGGGAAATCTGTT-GAATGGCC-3' (297 bp) and, as an invariant control, S16 ribosomal protein 5'-GGCAAGGAGCGATTTGCTGGTG-3', 5'-ACCAGGGCYTTTGAGATGGACTG-3' (102 bp, (Foley et al., 1993) ).
Oligonucleotide electrophoretic mobility shift assay
Cells before and after the induction of pRB or p107 for 24 h were used for E2F gel shift assay as described (Zhu et al., 1993) . Cell extract was precipitated with antibodies against pRB or p107. The immunoprecipitates were treated with 8% DOC and subsequently incubated with 32 P end labeled E2F site-containing oligonucleotides in the absence or presence of supershifting antibodies. Anti-E2F antibodies were previously shown to be able to recognize E2F gel shift complexes: anti-E2F1: KH20 ( ; anti-E2F2 and E2F3: sc-633 and sc-879 (Santa Cruz); and anti-E2F4: WUF10 (Woo et al., 1997) ). At the end of the reaction, the reaction mixture was separated on a natural polyacrylamide gel.
Northern blot analysis
Total RNA was isolated with the guanidinium method (Ausubel et al., 1990) . Northern analysis was performed with the Ambion NorthernMax kit according to manufacturer's instructions. Blots were sequentially probed with cDNA probes of corresponding human genes kindly provided by Anil Rustigi (c-myc exon one and two), Lars Thelander (RRM1), Peggy Farnham (DHFR), Dieter Wolf (hsOrc1), Sanders Williams (Cdc6), HR Knippers and Hans-Peter Holtho (MCM3, MCM4, MCM5, MCM6), Yukio Ishimi (MCM2), Jonathan Horowitz (MCM7), Anindya Dutta (Cdc25A), and Lee Johnson (mouse TS). Probes for cyclin A, cyclin E, Cdk2, Cdc2, Cdk4, E2F1, E2F3, E2F4 were prepared from respective expression constructs described previously Zhu et al., 1995b) . The B-myb probe was made by PCR. At rat GAPDH cDNA was used as control.
